重庆发现人感染 H7N9 病例 密切接触者未现异常

2017-03-07 佚名 中新网

中新网重庆 3 月 7 日电重庆市卫计委 6 日深夜在其官网上通报称,重庆奉节县发现一例人感染 H7N9 病例,与其密切接触者均未出现异常。

中新网重庆 3 月 7 日电重庆市卫计委 6 日深夜在其官网上通报称,重庆奉节县发现一例人感染 H7N9 病例,与其密切接触者均未出现异常。


记者致电重庆市卫计委,对方证实该通报情况属实。通报称,2017 年 3 月 4 日,奉节县监测报告 1 例不明原因肺炎病例。经采样检测并经复核,确诊为人感染 H7N9 病例。患者邓某,男,66 岁,目前正在住院积极治疗中,密切接触者均未出现异常。

中国疾病预防控制中心在此前召开的全国人感染 H7N9 禽流感疫情视频会商会上分析称,本流行季节的 H7N9 疫情较既往在病例流行病学特征、暴露模式和病原学特点方面,并没有发生大的变化。全国 H7N9 疫情总体上仍为散发态势。目前,H7N9 疫情仍处于可防可控状态。世界卫生组织此前公布的研究数据亦显示,尚无证据表明 H7N9 病毒会在人与人之间持续传播。

专家建议,市民在日常生活中应避免接触病死禽类,尤其应尽量避免直接接触活禽类、鸟类或其粪便,若接触,须尽快洗手;应购买有检疫证明的冷鲜禽、冰鲜禽及其产品;生禽肉和鸡蛋等一定要烧熟煮透,加工处理生禽肉和蛋类后要彻底洗手;食品加工过程中要做到生熟分开;培养健康的生活方式,尽可能保持正常的作息,加强体育锻炼;若有发热及呼吸道症状,应戴上口罩,尽快就诊。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2009658, encodeId=b4a2200965812, content=<a href='/topic/show?id=db44465364d' target=_blank style='color:#2F92EE;'>#密切接触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46536, encryptionId=db44465364d, topicName=密切接触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Thu Jul 13 01:56:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477525, encodeId=783c14e7525a6, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573896, encodeId=33ba15e3896ed, content=<a href='/topic/show?id=fb664653e2e' target=_blank style='color:#2F92EE;'>#密切接触者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46537, encryptionId=fb664653e2e, topicName=密切接触者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=323d15973114, createdName=zhangjingnwpu, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178729, encodeId=6c481e872976, content=关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Mar 08 07:21:15 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2009658, encodeId=b4a2200965812, content=<a href='/topic/show?id=db44465364d' target=_blank style='color:#2F92EE;'>#密切接触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46536, encryptionId=db44465364d, topicName=密切接触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Thu Jul 13 01:56:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477525, encodeId=783c14e7525a6, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573896, encodeId=33ba15e3896ed, content=<a href='/topic/show?id=fb664653e2e' target=_blank style='color:#2F92EE;'>#密切接触者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46537, encryptionId=fb664653e2e, topicName=密切接触者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=323d15973114, createdName=zhangjingnwpu, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178729, encodeId=6c481e872976, content=关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Mar 08 07:21:15 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2009658, encodeId=b4a2200965812, content=<a href='/topic/show?id=db44465364d' target=_blank style='color:#2F92EE;'>#密切接触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46536, encryptionId=db44465364d, topicName=密切接触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Thu Jul 13 01:56:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477525, encodeId=783c14e7525a6, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573896, encodeId=33ba15e3896ed, content=<a href='/topic/show?id=fb664653e2e' target=_blank style='color:#2F92EE;'>#密切接触者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46537, encryptionId=fb664653e2e, topicName=密切接触者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=323d15973114, createdName=zhangjingnwpu, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178729, encodeId=6c481e872976, content=关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Mar 08 07:21:15 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2009658, encodeId=b4a2200965812, content=<a href='/topic/show?id=db44465364d' target=_blank style='color:#2F92EE;'>#密切接触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46536, encryptionId=db44465364d, topicName=密切接触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Thu Jul 13 01:56:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477525, encodeId=783c14e7525a6, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573896, encodeId=33ba15e3896ed, content=<a href='/topic/show?id=fb664653e2e' target=_blank style='color:#2F92EE;'>#密切接触者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46537, encryptionId=fb664653e2e, topicName=密切接触者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=323d15973114, createdName=zhangjingnwpu, createdTime=Thu Mar 09 05:56:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178729, encodeId=6c481e872976, content=关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Mar 08 07:21:15 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2017-03-08 stupidox

    关注一下

    0

相关资讯

MedSci“临床科研中国行”全国巡回讲座重庆站圆满落幕

         MedSci“临床科研中国行”全国巡回讲座重庆站于2010年9月17号圆满落幕。本次讲座的主要内容有:1. 临床SCI论文选题;2. SCI论文发表支持与期刊选择技巧;3. 临床资料如何转化成SCI文章;4. 从REVIEWER角度看SCI文章。讲座吸引了大批MedSci新老客户的参与,MedSci资

重庆“七天短命医改” 幕后原因揭秘

从3月25日到3月31日,重庆医改仅仅持续七天便宣告结束。这场以医疗服务项目价格调整为内容的医改,因大幅度增加了部分患者经济负担,引起了部分市民上街抵制。医改相关推动部门向公众道歉,并承认“考虑不周”。 重庆医改起始于2012年,背景是国家发展改革委、卫生部等部门下发文件要求各地加快医疗服务价格改革步伐,理顺医疗服务项目比价关系;目的是破除以药补医、充分调动医务人员积极性等。 专家

预告:MedSci“临床科研中国行”全国巡回讲座(四川、重庆站)

        MedSci是综合临床医学和科研学术服务平台,致力于从事医学临床和科研的教育、培训和医学学术服务指导,全面提升中国医学和科研学术水平,全面对接中国和国际最新研究成果。        继八月北京六大三甲医院的讲座之后,MedSci将于9月在四川、

MedSci“临床科研中国行”全国巡回讲座四川成都站圆满落幕

        MedSci“临床科研中国行”全国巡回讲座四川成都站于2010年9月10日圆满落幕。SCI论文发表支持与期刊选择技巧的主题讲座吸引了大批MedSci新老客户的参与,MedSci资深编辑将MedSci处理过的数万篇中国论文的宝贵经验,结合中国学者在论文写作中常见的问题,与广大师生互动交流、学习,并和在场的

重庆“两票制”落地,今年5月31前为过渡期

“两票制”真正落地,药品流通环境流程将得到重塑,药品价格虚高、走票、倒票、医药贿赂等问题能够得到有效地控制。但是旧有的药品流通体系不可能在短时间内转变,所以政策出台时为药企、流通企业、医院预留了过渡期。重庆两票制最接近国家版1月3日,重庆市卫计委网站发布《关于印发重庆市公立医疗机构药品采购“两票制”实施方案(试行)的通知》。《通知》称,《重庆市公立医疗机构药品采购“两票制”实施方案(试行)》(